Needham: Peloton is a key beneficiary of COVID-19

Yahoo Finance Video
4 months ago
On Friday, Needham analysts reiterated their buy rating — and $50 price target — on shares of Peloton following comments by the company’s CFO, Jill Woodworth. The firm’s argument was that Peloton has been a key beneficiary of COVID-19 and will continue to do so. The Final Round panel discusses.
Hot Items
Up-to-the-minute finance news, trusted tips and interviews.